<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9277478" created="21/03/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9277478</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="alpha-Tocopheryl_succinate" sem="Organic_compound_other">alpha-Tocopheryl succinate</term> inhibits <term id="T2" lex="monocytic_cell_adhesion" sem="Other"><term id="A1" sem="Cell_natural">monocytic cell</term> adhesion</term> to <term id="T3" lex="endothelial_cell" sem="Cell_natural">endothelial cells</term> by suppressing <term id="T4" lex="NF-kappa_B_mobilization" sem="Other"><term id="T5" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> mobilization</term>.</sentence>
<event KT="Other" id="E1">
<type class="Cell_adhesion"/>
<theme idref="A1"/>
<theme idref="T3"/>
<clue>alpha-Tocopheryl succinate inhibits monocytic cell <clueType>adhesion</clueType> <linkTheme>to</linkTheme> endothelial cells by suppressing NF-kappa B mobilization.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="E4"/>
<clue>alpha-Tocopheryl succinate <clueType>inhibits</clueType> monocytic cell adhesion to endothelial cells <linkCause>by</linkCause> suppressing NF-kappa B mobilization.</clue>
</event>
<event KT="Other" id="E3">
<type class="Localization"/>
<theme idref="T5"/>
<clue>alpha-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B <clueType>mobilization</clueType>.</clue>
</event>
<event id="E4">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="T1"/>
<clue>alpha-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by <clueType>suppressing</clueType> NF-kappa B mobilization.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The adherence of <term id="T6" lex="monocyte" sem="Cell_natural">monocytes</term> to <term id="T7" lex="activated_endothelium" sem="Tissue_natural">activated <term id="A2" sem="Tissue_natural">endothelium</term></term> is an early event in <term id="T8" lex="atherogenesis" sem="Other">atherogenesis</term>.</sentence>
<event KT="Other" id="E5">
<type class="Physiological_process"/>
<theme idref="A2"/>
<clue>The adherence of monocytes to <clueType>activated</clueType> endothelium is an early event in atherogenesis.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Cell_adhesion"/>
<theme idref="T6"/>
<theme idref="T7"/>
<clue>The <clueType>adherence</clueType> <linkTheme>of</linkTheme> monocytes <linkTheme>to</linkTheme> activated endothelium is an <clueTime>early event</clueTime> in atherogenesis.</clue>
</event>
<sentence id="S3">Because antioxidants have been considered to be of <term id="T9" lex="antiatherosclerotic_potential" sem="Other">antiatherosclerotic potential</term>, we investigated the effects of <term id="T10" lex="alpha-tocopherol" sem="Organic_compound_other">alpha-tocopherol</term> (<term id="T11" lex="TCP" sem="Organic_compound_other">TCP</term>) and its <term id="A10" sem="Organic_compound_other">acetate</term> and <term id="A11" sem="Organic_compound_other">succinate</term> esters on <term id="T12" lex="monocyte_adhesion" sem="Other"><term id="A3" sem="Cell_natural">monocyte</term> adhesion</term> to <term id="T13" lex="cytokine-stimulated_human_umbilical_vein_endothelial_cells" sem="Cell_cultured"><term id="A20" sem="Cell_cultured"><term id="A4" sem="Protein_family_or_group">cytokine</term>-stimulated</term> human umbilical vein <term id="T14" lex="endothelial_cell" sem="Cell_natural">endothelial cells</term></term> (<term id="T15" lex="HUVEC" sem="Cell_cultured">HUVEC</term>).</sentence>
<event KT="Investigation" id="E26" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T11"/>
<clue>Because antioxidants have been considered to be of antiatherosclerotic potential, we <clueKT>investigated</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> alpha-tocopherol (TCP) and its acetate and succinate esters <linkTheme>on</linkTheme> monocyte adhesion to cytokine-stimulated human umbilical vein endothelial cells (HUVEC).</clue>
</event>
<event KT="Investigation" id="E27" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T11" idref1="A10"/>
<clue>Because antioxidants have been considered to be of antiatherosclerotic potential, we <clueKT>investigated</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> alpha-tocopherol (TCP) and its acetate and succinate esters <linkTheme>on</linkTheme> monocyte adhesion to cytokine-stimulated human umbilical vein endothelial cells (HUVEC).</clue>
</event>
<event KT="Investigation" id="E28" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T11" idref1="A11"/>
<clue>Because antioxidants have been considered to be of antiatherosclerotic potential, we <clueKT>investigated</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> alpha-tocopherol (TCP) and its acetate and succinate esters <linkTheme>on</linkTheme> monocyte adhesion to cytokine-stimulated human umbilical vein endothelial cells (HUVEC).</clue>
</event>
<event KT="Other" id="E7">
<type class="Physiological_process"/>
<theme idref="T15"/>
<cause idref="A4"/>
<clue>Because antioxidants have been considered to be of antiatherosclerotic potential, we investigated the effects of alpha-tocopherol (TCP) and its acetate and succinate esters on monocyte adhesion to cytokine-<clueType>stimulated</clueType> human umbilical vein endothelial cells (HUVEC).</clue>
</event>
<event KT="Other" id="E8">
<type class="Cell_adhesion"/>
<theme idref="A3"/>
<theme idref="A20" idref1="T15"/>
<clue>Because antioxidants have been considered to be of antiatherosclerotic potential, we investigated the effects of alpha-tocopherol (TCP) and its acetate and succinate esters on monocyte <clueType>adhesion</clueType> <linkTheme>to</linkTheme> cytokine-stimulated human umbilical vein endothelial cells (HUVEC).</clue>
</event>
<sentence id="S4"><term id="T16" lex="endothelial_cell" sem="Cell_natural">Endothelial cells</term> were treated with <term id="T17" lex="TCP" sem="Organic_compound_other">TCP</term>, <term id="T18" lex="alpha-tocopherol_acetate" sem="Organic_compound_other">alpha-tocopherol acetate</term> (<term id="T19" lex="TCP_acetate" sem="Organic_compound_other">TCP acetate</term>), or <term id="T20" lex="alpha-tocopheryl_succinate" sem="Organic_compound_other">alpha-tocopheryl succinate</term> (<term id="T21" lex="TCP_succinate" sem="Organic_compound_other">TCP succinate</term>) before stimulation with <term id="T22" lex="tumor_necrosis_factor-alpha" sem="Protein_molecule">tumor necrosis factor-alpha</term> (<term id="T23" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>; 10 U/ml, 6 h) or <term id="T24" lex="interleukin-1_beta" sem="Protein_molecule">interleukin-1 beta</term> (<term id="T25" lex="IL-1_beta" sem="Protein_molecule">IL-1 beta</term>; 10 U/ml, 6 h).</sentence>
<event id="E9">
<type class="Physiological_process"/>
<theme idref="T16"/>
<cause idref="T23"/>
<clue>Endothelial cells were treated with TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) before <clueType>stimulation</clueType> <linkCause>with</linkCause> tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<event id="E10">
<type class="Physiological_process"/>
<theme idref="T16"/>
<cause idref="T25"/>
<clue>Endothelial cells were treated with TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) before <clueType>stimulation</clueType> <linkCause>with</linkCause> tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<event id="E11">
<type class="Physiological_process"/>
<theme idref="T16"/>
<cause idref="T23"/>
<clue>Endothelial cells were treated with TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) before <clueType>stimulation</clueType> <linkCause>with</linkCause> tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<event id="E12">
<type class="Physiological_process"/>
<theme idref="T16"/>
<cause idref="T25"/>
<clue>Endothelial cells were treated with TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) before <clueType>stimulation</clueType> <linkCause>with</linkCause> tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<event id="E13">
<type class="Physiological_process"/>
<theme idref="T16"/>
<cause idref="T23"/>
<clue>Endothelial cells were treated with TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) before <clueType>stimulation</clueType> <linkCause>with</linkCause> tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<event id="E29">
<type class="Physiological_process"/>
<theme idref="T16"/>
<cause idref="T25"/>
<clue>Endothelial cells were treated with TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) before <clueType>stimulation</clueType> <linkCause>with</linkCause> tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<event KT="Method" id="E14">
<type class="Artificial_process"/>
<theme idref="T16"/>
<theme idref="T17"/>
<clue>Endothelial cells were <clueType>treated</clueType> <linkTheme>with</linkTheme> TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) <clueTime>before stimulation</clueTime> with tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<event KT="Method" id="E15">
<type class="Artificial_process"/>
<theme idref="T16"/>
<theme idref="T19"/>
<clue>Endothelial cells were <clueType>treated</clueType> <linkTheme>with</linkTheme> TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) <clueTime>before stimulation</clueTime> with tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<event KT="Method" id="E16">
<type class="Artificial_process"/>
<theme idref="T16"/>
<theme idref="T21"/>
<clue>Endothelial cells were <clueType>treated</clueType> <linkTheme>with</linkTheme> TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) <clueTime>before stimulation</clueTime> with tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h).</clue>
</event>
<sentence id="S5"><term id="A12" sem="Protein_family_or_group">Cytokine</term>-stimulated <term id="A13" sem="Cell_natural">cell</term> surface expression of <term id="T26" lex="vascular_cell_adhesion_molecule-1" sem="Protein_molecule">vascular cell adhesion molecule-1</term> (<term id="T27" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term>, <term id="T28" lex="CD106" sem="Protein_molecule">CD106</term>) and <term id="T29" lex="E-selectin" sem="Protein_molecule">E-selectin</term> (<term id="T30" lex="ELAM-1" sem="Protein_molecule">ELAM-1</term>, <term id="T31" lex="CD62E" sem="Protein_molecule">CD62E</term>), but not of <term id="T32" lex="intercellular_adhesion_molecule-1" sem="Protein_molecule">intercellular adhesion molecule-1</term> (<term id="T33" lex="ICAM-1" sem="Protein_molecule">ICAM-1</term>, <term id="T34" lex="CD54" sem="Protein_molecule">CD54</term>), was time- and dose-dependently inhibited by <term id="T35" lex="TCP_succinate" sem="Organic_compound_other">TCP succinate</term> but not by <term id="T36" lex="TCP" sem="Organic_compound_other">TCP</term> or <term id="T37" lex="TCP_acetate" sem="Organic_compound_other">TCP acetate</term>.</sentence>
<event id="E47">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="A12"/>
<clue>Cytokine-<clueType>stimulated</clueType> cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently inhibited by TCP succinate but not by TCP or TCP acetate.</clue>
</event>
<event id="E17">
<type class="Gene_expression"/>
<theme idref="T27"/>
<clue>Cytokine-stimulated <clueLoc>cell surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently inhibited by TCP succinate but not by TCP or TCP acetate.</clue>
</event>
<event id="E18">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T35"/>
<clue>Cytokine-stimulated cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently <clueType>inhibited</clueType> <linkCause>by</linkCause> TCP succinate but not by TCP or TCP acetate.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E19">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T36"/>
<clue>Cytokine-stimulated cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently <clueType>inhibited</clueType> by TCP succinate but <cluePolarity>not</cluePolarity> <linkCause>by</linkCause> TCP or TCP acetate.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E20">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T37"/>
<clue>Cytokine-stimulated cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently <clueType>inhibited</clueType> by TCP succinate but <cluePolarity>not</cluePolarity> <linkCause>by</linkCause> TCP or TCP acetate.</clue>
</event>
<event id="E21">
<type class="Gene_expression"/>
<theme idref="T30"/>
<clue><clueLoc>Cytokine-stimulated cell</clueLoc> <clueLoc>surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently inhibited by TCP succinate but not by TCP or TCP acetate.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T35"/>
<clue>Cytokine-stimulated cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently <clueType>inhibited</clueType> <linkCause>by</linkCause> TCP succinate but not by TCP or TCP acetate.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E23">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T36"/>
<clue>Cytokine-stimulated cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently <clueType>inhibited</clueType> by TCP succinate but <cluePolarity>not</cluePolarity> <linkCause>by</linkCause> TCP or TCP acetate.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E24">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T37"/>
<clue>Cytokine-stimulated cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently <clueType>inhibited</clueType> by TCP succinate but <cluePolarity>not</cluePolarity> by TCP or TCP acetate.</clue>
</event>
<event id="E25">
<type class="Gene_expression"/>
<theme idref="T33"/>
<clue><clueLoc>Cytokine-stimulated cell</clueLoc> <clueLoc>surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently inhibited by TCP succinate but not by TCP or TCP acetate.</clue>
</event>
<event assertion="non-exist" id="E31">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="T35"/>
<clue>Cytokine-stimulated cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently <clueType>inhibited</clueType> <linkCause>by</linkCause> TCP succinate but not by TCP or TCP acetate.</clue>
</event>
<sentence id="S6"><term id="T38" lex="TCP_succinate" sem="Organic_compound_other">TCP succinate</term> (200 microM, 24 h) reduced <term id="T39" lex="TNF-induced_VCAM-1" sem="Protein_molecule"><term id="A5" sem="Protein_molecule">TNF</term>-induced <term id="T40" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term></term> and <term id="T41" lex="E-selectin" sem="Protein_molecule">E-selectin</term> expression from a <term id="T42" lex="specific_mean_fluorescence_intensity" sem="Other">specific mean fluorescence intensity</term> of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively.</sentence>
<event id="E30">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>TCP succinate (200 microM, 24 h) reduced TNF-induced VCAM-1 and E-selectin <clueType>expression</clueType> from a specific mean fluorescence intensity of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively.</clue>
</event>
<event id="E32">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>TCP succinate (200 microM, 24 h) reduced TNF-induced VCAM-1 and E-selectin <clueType>expression</clueType> from a specific mean fluorescence intensity of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively.</clue>
</event>
<event id="E59">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="A5"/>
<clue>TCP succinate (200 microM, 24 h) reduced TNF-<clueType>induced</clueType> VCAM-1 and E-selectin expression from a specific mean fluorescence intensity of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively.</clue>
</event>
<event id="E60">
<type class="Positive_regulation"/>
<theme idref="E32"/>
<cause idref="A5"/>
<clue>TCP succinate (200 microM, 24 h) reduced TNF-<clueType>induced</clueType> VCAM-1 and E-selectin expression from a specific mean fluorescence intensity of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively.</clue>
</event>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="E59"/>
<cause idref="T38"/>
<clue>TCP succinate (200 microM, 24 h) <clueType>reduced</clueType> TNF-induced VCAM-1 and E-selectin expression from a specific mean fluorescence intensity of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively.</clue>
</event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E60"/>
<cause idref="T38"/>
<clue>TCP succinate (200 microM, 24 h) <clueType>reduced</clueType> TNF-induced VCAM-1 and E-selectin expression from a specific mean fluorescence intensity of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively.</clue>
</event>
<sentence id="S7"><term id="T43" lex="succinate" sem="Organic_compound_other">Succinate</term> alone had no effect.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E35">
<type class="Regulation"/>
<theme idref="E30"/>
<cause idref="T43"/>
<clue>Succinate alone had <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>NO COREFTHEME</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E61">
<type class="Regulation"/>
<theme idref="E32"/>
<cause idref="T43"/>
<clue>Succinate alone had <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>NO COREFTHEME</comment></event>
<sentence id="S8">Decreased <term id="T44" lex="adhesion_molecule_expression" sem="Other"><term id="T45" lex="adhesion_molecule" sem="Protein_family_or_group">adhesion molecule</term> expression</term> was associated with a reduction of <term id="T46" lex="monocytic_cell_adhesion" sem="Other"><term id="A6" sem="Cell_natural">monocytic cell</term> adhesion</term>.</sentence>
<event KT="Other" id="E36">
<type class="Gene_expression"/>
<theme idref="T45"/>
<clue>Decreased adhesion molecule <clueType>expression</clueType> was associated with a reduction of monocytic cell adhesion.</clue>
</event>
<event KT="Other" id="E37">
<type class="Negative_regulation"/>
<theme idref="E36"/>
<clue><clueType>Decreased</clueType> adhesion molecule expression was associated with a reduction of monocytic cell adhesion.</clue>
</event>
<event KT="Other" id="E38">
<type class="Cell_adhesion"/>
<theme idref="A6"/>
<clue>Decreased adhesion molecule expression was associated with a reduction of monocytic cell <clueType>adhesion</clueType>.</clue>
</event>
<event KT="Other" id="E39">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<clue>Decreased adhesion molecule expression was associated with a <clueType>reduction</clueType> <linkTheme>of</linkTheme> monocytic cell adhesion.</clue>
</event>
<event KT="Analysis" id="E40">
<type class="Correlation"/>
<theme idref="E37"/>
<theme idref="E39"/>
<clue>Decreased adhesion molecule expression was <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> a reduction of monocytic cell adhesion.</clue>
</event>
<sentence id="S9"><term id="T47" lex="TCP_succinate" sem="Organic_compound_other">TCP succinate</term> (20 microM, 72 h), but not <term id="T48" lex="TCP" sem="Organic_compound_other">TCP</term> (200 microM, 72 h), reduced <term id="T49" lex="U-937_cell_adhesion" sem="Other"><term id="T50" lex="U-937_cell" sem="Cell_cultured">U-937 cell</term> adhesion</term> to <term id="T51" lex="TNF-alpha-stimulated_(10_U/ml,_6_h)_HUVEC" sem="Cell_cultured"><term id="A21" sem="Cell_cultured"><term id="T52" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>-stimulated</term> (10 U/ml, 6 h) <term id="T53" lex="HUVEC" sem="Cell_cultured">HUVEC</term></term> by 30% (P &lt; 0.025) and to <term id="T54" lex="IL-1_beta-stimulated_HUVEC" sem="Cell_cultured"><term id="T55" lex="IL-1_beta" sem="Protein_molecule">IL-1 beta</term>-stimulated <term id="T56" lex="HUVEC" sem="Cell_cultured">HUVEC</term></term> by 56% (P &lt; 0.010).</sentence>
<event id="E41">
<type class="Physiological_process"/>
<theme idref="T53"/>
<cause idref="T52"/>
<clue>TCP succinate (20 microM, 72 h), but not TCP (200 microM, 72 h), reduced U-937 cell adhesion to TNF-alpha-<clueType>stimulated</clueType> (10 U/ml, 6 h) HUVEC by 30% (P &lt; 0.025) and to IL-1 beta-stimulated HUVEC by 56% (P &lt; 0.010).</clue>
</event>
<event id="E42">
<type class="Cell_adhesion"/>
<theme idref="T50"/>
<theme idref="A21" idref1="T53"/>
<clue>TCP succinate (20 microM, 72 h), but not TCP (200 microM, 72 h), reduced U-937 cell <clueType>adhesion</clueType> <linkTheme>to</linkTheme> TNF-alpha-stimulated (10 U/ml, 6 h) HUVEC by 30% (P &lt; 0.025) and to IL-1 beta-stimulated HUVEC by 56% (P &lt; 0.010).</clue>
</event>
<event id="E43">
<type class="Physiological_process"/>
<theme idref="T56"/>
<cause idref="T55"/>
<clue>TCP succinate (20 microM, 72 h), but not TCP (200 microM, 72 h), reduced U-937 cell adhesion to TNF-alpha-stimulated (10 U/ml, 6 h) HUVEC by 30% (P &lt; 0.025) and to IL-1 beta-<clueType>stimulated</clueType> HUVEC by 56% (P &lt; 0.010).</clue>
</event>
<event id="E44">
<type class="Cell_adhesion"/>
<theme idref="T50"/>
<theme idref="T54"/>
<clue>TCP succinate (20 microM, 72 h), but not TCP (200 microM, 72 h), reduced U-937 cell <clueType>adhesion</clueType> to TNF-alpha-stimulated (10 U/ml, 6 h) HUVEC by 30% (P &lt; 0.025) and <linkTheme>to</linkTheme> IL-1 beta-stimulated HUVEC by 56% (P &lt; 0.010).</clue>
</event>
<event id="E45">
<type class="Negative_regulation"/>
<theme idref="E42"/>
<cause idref="T47"/>
<clue>TCP succinate (20 microM, <clueTime>72 h</clueTime>), but not TCP (200 microM, 72 h), <clueType>reduced</clueType> U-937 cell adhesion to TNF-alpha-stimulated (10 U/ml, 6 h) HUVEC by 30% (P &lt; 0.025) and to IL-1 beta-stimulated HUVEC by 56% (P &lt; 0.010).</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E62">
<type class="Negative_regulation"/>
<theme idref="E42"/>
<cause idref="T48"/>
<clue>TCP succinate (20 microM, <clueTime>72 h</clueTime>), but <cluePolarity>not</cluePolarity> TCP (200 microM, 72 h), <clueType>reduced</clueType> U-937 cell adhesion to TNF-alpha-stimulated (10 U/ml, 6 h) HUVEC by 30% (P &lt; 0.025) and to IL-1 beta-stimulated HUVEC by 56% (P &lt; 0.010).</clue>
</event>
<event id="E46">
<type class="Negative_regulation"/>
<theme idref="E44"/>
<cause idref="T47"/>
<clue>TCP succinate (20 microM, 72 h), but not TCP (200 microM, <clueTime>72 h</clueTime>), <clueType>reduced</clueType> U-937 cell adhesion to TNF-alpha-stimulated (10 U/ml, 6 h) HUVEC by 30% (P &lt; 0.025) and to IL-1 beta-stimulated HUVEC by 56% (P &lt; 0.010).</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E63">
<type class="Negative_regulation"/>
<theme idref="E44"/>
<cause idref="T48"/>
<clue>TCP succinate (20 microM, 72 h), but <cluePolarity>not</cluePolarity> TCP (200 microM, <clueTime>72 h</clueTime>), <clueType>reduced</clueType> U-937 cell adhesion to TNF-alpha-stimulated (10 U/ml, 6 h) HUVEC by 30% (P &lt; 0.025) and to IL-1 beta-stimulated HUVEC by 56% (P &lt; 0.010).</clue>
</event>
<sentence id="S10"><term id="T57" lex="electrophoretic_mobility-shift_assay" sem="Other">Electrophoretic mobility-shift assays</term> of <term id="T58" lex="HUVEC" sem="Cell_cultured">HUVEC</term> <term id="T59" lex="nuclear_protein" sem="Protein_family_or_group">nuclear proteins</term> revealed a decrease in <term id="T60" lex="TNF-alpha-stimulated_nuclear_factor-kappa_B" sem="Protein_molecule"><term id="T61" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>-stimulated nuclear factor-kappa B</term> (<term id="T62" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>) activation after pretreatment of <term id="T63" lex="HUVEC" sem="Cell_cultured">HUVEC</term> with <term id="T64" lex="TCP_succinate" sem="Organic_compound_other"><term id="T65" lex="TCP" sem="Organic_compound_other">TCP</term> succinate</term> but not with <term id="T66" lex="TCP" sem="Organic_compound_other">TCP</term>, <term id="T67" lex="TCP_acetate" sem="Organic_compound_other">TCP acetate</term>, or <term id="T68" lex="succinate" sem="Organic_compound_other">succinate</term> alone.</sentence>
<event KT="Other" id="E48">
<type class="Positive_regulation"/>
<theme idref="T62"/>
<cause idref="T61"/>
<clue>Electrophoretic mobility-shift assays of HUVEC nuclear proteins revealed a decrease in TNF-alpha<linkCause>-stimulated</linkCause> nuclear factor-kappa B (NF-kappa B) <clueType>activation</clueType> after pretreatment of HUVEC with TCP succinate but not with TCP, TCP acetate, or succinate alone.</clue>
</event>
<event KT="Analysis" id="E49">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="E64"/>
<clue><clueExperiment>Electrophoretic mobility-shift assays</clueExperiment> of HUVEC nuclear proteins <clueKT>revealed</clueKT> a <clueType>decrease</clueType> <linkTheme>in</linkTheme> TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation <linkCause>after</linkCause> pretreatment of HUVEC with TCP succinate but not with TCP, TCP acetate, or succinate alone.</clue>
</event>
<event KT="Analysis" assertion="non-exist" id="E50">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="E65"/>
<clue><clueExperiment>Electrophoretic mobility-shift assays</clueExperiment> of HUVEC nuclear proteins <clueKT>revealed</clueKT> a <clueType>decrease</clueType> <linkTheme>in</linkTheme> TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation <linkCause>after</linkCause> pretreatment of HUVEC with TCP succinate but not with TCP, TCP acetate, or succinate alone.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E51">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="E66"/>
<clue><clueExperiment>Electrophoretic mobility-shift assays</clueExperiment> of HUVEC nuclear proteins <clueKT>revealed</clueKT> a <clueType>decrease</clueType> <linkTheme>in</linkTheme> TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation <linkCause>after</linkCause> pretreatment of HUVEC with TCP succinate but <cluePolarity>not</cluePolarity> with TCP, TCP acetate, or succinate alone.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E52">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="E67"/>
<clue><clueExperiment>Electrophoretic mobility-shift assays</clueExperiment> of HUVEC nuclear proteins <clueKT>revealed</clueKT> a <clueType>decrease</clueType> <linkTheme>in</linkTheme> TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation <linkCause>after</linkCause> pretreatment of HUVEC with TCP succinate but <cluePolarity>not</cluePolarity> with TCP, TCP acetate, or succinate alone.</clue>
</event>
<event KT="Method" id="E64">
<type class="Artificial_process"/>
<theme idref="T63"/>
<theme idref="T64"/>
<clue>Electrophoretic mobility-shift assays of HUVEC nuclear proteins revealed a decrease in TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation after <clueType>pretreatment</clueType> <linkTheme>of</linkTheme> HUVEC <linkTheme>with</linkTheme> TCP succinate but not with TCP, TCP acetate, or succinate alone.</clue>
</event>
<event KT="Method" id="E65">
<type class="Artificial_process"/>
<theme idref="T63"/>
<theme idref="T66"/>
<clue>Electrophoretic mobility-shift assays of HUVEC nuclear proteins revealed a decrease in TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation after <clueType>pretreatment</clueType> <linkTheme>of</linkTheme> HUVEC <linkTheme>with</linkTheme> TCP succinate but not with TCP, TCP acetate, or succinate alone.</clue>
</event>
<event KT="Method" id="E66">
<type class="Artificial_process"/>
<theme idref="T63"/>
<theme idref="T67"/>
<clue>Electrophoretic mobility-shift assays of HUVEC nuclear proteins revealed a decrease in TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation after <clueType>pretreatment</clueType> <linkTheme>of</linkTheme> HUVEC <linkTheme>with</linkTheme> TCP succinate but not with TCP, TCP acetate, or succinate alone.</clue>
</event>
<event KT="Method" id="E67">
<type class="Artificial_process"/>
<theme idref="T63"/>
<theme idref="T68"/>
<clue>Electrophoretic mobility-shift assays of HUVEC nuclear proteins revealed a decrease in TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation after <clueType>pretreatment</clueType> <linkTheme>of</linkTheme> HUVEC <linkTheme>with</linkTheme> TCP succinate but not with TCP, TCP acetate, or succinate alone.</clue>
</event>
<sentence id="S11">In conclusion, we demonstrate that the <term id="T69" lex="vitamin_E_derivative" sem="Organic_compound_other">vitamin E derivative</term> <term id="T70" lex="TCP_succinate" sem="Organic_compound_other">TCP succinate</term> prevents <term id="T71" lex="monocytic_cell_adhesion" sem="Other"><term id="A7" sem="Cell_natural">monocytic cell</term> adhesion</term> to <term id="A23" sem="Cell_cultured"><term id="A8" sem="Protein_family_or_group">cytokine</term>-stimulated <term id="T72" lex="endothelial_cell" sem="Cell_natural">endothelial cells</term></term> by inhibiting the activation of <term id="T73" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>, further emphasizing the <term id="T74" lex="antiatherosclerotic_potential" sem="Other">antiatherosclerotic potential</term> of <term id="T75" lex="lipid_soluble_antioxidant" sem="Organic_compound_other">lipid soluble antioxidants</term>.</sentence>
<event KT="Other" id="E53">
<type class="Cell_adhesion"/>
<theme idref="A7"/>
<theme idref="A23"/>
<clue>In conclusion, we demonstrate that the vitamin E derivative TCP succinate prevents monocytic cell <clueType>adhesion</clueType> <linkTheme>to</linkTheme> cytokine-stimulated endothelial cells by inhibiting the activation of NF-kappa B, further emphasizing the antiatherosclerotic potential of lipid soluble antioxidants.</clue>
</event>
<event KT="Other" id="E54">
<type class="Physiological_process"/>
<theme idref="T72"/>
<cause idref="A8"/>
<clue>In conclusion, we demonstrate that the vitamin E derivative TCP succinate prevents monocytic cell adhesion to cytokine-<clueType>stimulated</clueType> endothelial cells by inhibiting the activation of NF-kappa B, further emphasizing the antiatherosclerotic potential of lipid soluble antioxidants.</clue>
</event>
<event KT="Analysis" id="E55">
<type class="Negative_regulation"/>
<theme idref="E53"/>
<cause idref="E57"/>
<clue><clueKT>In conclusion</clueKT>, we <clueKT>demonstrate</clueKT> that the vitamin E derivative TCP succinate <clueType>prevents</clueType> monocytic cell adhesion to cytokine-stimulated endothelial cells <linkCause>by</linkCause> inhibiting the activation of NF-kappa B, further emphasizing the antiatherosclerotic potential of lipid soluble antioxidants.</clue>
</event>
<event KT="Other" id="E56">
<type class="Positive_regulation"/>
<theme idref="T73"/>
<clue>In conclusion, we demonstrate that the vitamin E derivative TCP succinate prevents monocytic cell adhesion to cytokine-stimulated endothelial cells by inhibiting the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B, further emphasizing the antiatherosclerotic potential of lipid soluble antioxidants.</clue>
</event>
<event KT="Other" id="E57">
<type class="Negative_regulation"/>
<theme idref="E56"/>
<cause idref="T70"/>
<clue>In conclusion, we demonstrate that the vitamin E derivative TCP succinate prevents monocytic cell adhesion to cytokine-stimulated endothelial cells by <clueType>inhibiting</clueType> the activation of NF-kappa B, further emphasizing the antiatherosclerotic potential of lipid soluble antioxidants.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
